Free 7-day Trial
All Articles and Columns »

Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 50,000 Shares

October 04, 2010 | About:
insider

insider

52 followers
CEO & Chairman of the Board, 10% Owner of Pain Therapeutics (PTIE) Remi Barbier sells 50,000 shares of PTIE on 10/04/2010 at an average price of $6.2 a share.

Pain Therapeutics has a market cap of $259.2 million; its shares were traded at around $6.07 with and P/S ratio of 12.6.

PTIE is in the portfolios of Jim Simons of Renaissance Technologies LLC, Mario Gabelli of GAMCO Investors.

This is the annual revenues and earnings per share of PTIE over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of PTIE.


CEO Recent Trades:



  • Sell: CEO & Chairman of the Board, 10% Owner Remi Barbier sold 28,597 shares of PTIE stock on 09/07/2010 at the average price of 5.69. Remi Barbier owns at least 5,979,587 shares after this. The price of the stock has increased by 6.68% since.

  • Sell: CEO & Chairman of the Board, 10% Owner Remi Barbier sold 21,403 shares of PTIE stock on 09/02/2010 at the average price of 5.81. Remi Barbier owns at least 6,008,184 shares after this. The price of the stock has increased by 4.48% since.

  • Sell: CEO & Chairman of the Board, 10% Owner Remi Barbier sold 19,469 shares of PTIE stock on 08/09/2010 at the average price of 5.64. Remi Barbier owns at least 6,029,587 shares after this. The price of the stock has increased by 7.62% since.

  • Sell: CEO & Chairman of the Board, 10% Owner Remi Barbier sold 22,391 shares of PTIE stock on 08/04/2010 at the average price of 5.71. Remi Barbier owns at least 6,049,056 shares after this. The price of the stock has increased by 6.3% since.

  • Sell: CEO and Chairman of the Board, 10% Owner Remi Barbier sold 27,243 shares of PTIE stock on 07/07/2010 at the average price of 5.35. Remi Barbier owns at least 6,071,447 shares after this. The price of the stock has increased by 13.46% since.




This is the insider trade history vs. stock price of PTIE. For the complete insider trading history of PTIE, click here.




Directors and Officers Recent Trades:



  • Sell: Chief Scientific Officer Grant Schoenhard sold 1,500 shares of PTIE stock on 07/16/2010 at the average price of 5.54. Grant Schoenhard owns at least 48,157 shares after this. The price of the stock has increased by 9.57% since.

  • Sell: Chief Scientific Officer Grant Schoenhard sold 1,500 shares of PTIE stock on 06/16/2010 at the average price of 5.45. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has increased by 11.38% since.

  • Sell: Chief Scientific Officer Grant Schoenhard sold 10,979 shares of PTIE stock on 05/27/2010 at the average price of 5.74. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has increased by 5.75% since.

  • Sell: Chief Scientific Officer Grant Schoenhard sold 2,486 shares of PTIE stock on 05/19/2010 at the average price of 5.77. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has increased by 5.2% since.

  • Sell: Chief Scientific Officer Grant Schoenhard sold 13,035 shares of PTIE stock on 05/18/2010 at the average price of 5.77. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has increased by 5.2% since.



About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 2.0/5 (3 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide